AMCP Position Statements

See how AMCP advocates for you. Stay informed on the latest policy actions and position statements shaping legislation and pharmacy practice so you can understand what’s changing and why it matters for your work in managed care pharmacy.

Meet the Board of Directors

Shaping Practice Standards in Managed Care Pharmacy

AMCP’s nearly 8,000 members work to improve the health of more than 200 million Americans through managed care pharmacy. Our Position Statements reflect AMCP’s stance on key professional and practice issues, guiding members in their roles and supporting advocacy with policymakers and stakeholders. Approved by the AMCP Board of Directors, these concise statements help define the responsibilities of managed care pharmacists, ensuring medications are used safely, effectively, and affordably.

Drug Information
Legislative & Regulatory Position

340B Drug Pricing Program

The Academy of Managed Care Pharmacy (AMCP) supports reforming the 340B Drug Pricing Program. While the program is intended to serve as an essential safety net that allows eligible healthcare entities to stretch federal resources and improve pharmaceutical access for vulnerable populations, stronger oversight, transparency, and accountability mechanisms are necessary to ensure it operates as Congress intended and delivers maximum benefit to patients and communities.
Legislation & Regulation, Price Transparency
Research
Legislative & Regulatory Position

Comparative Effectiveness Research and Patient‐Centered Outcomes Research

The Academy of Managed Care Pharmacy (AMCP) supports scientifically-sound research that compares the effectiveness and value of medications and treatments, as well as research aimed at tailoring treatment options to individual patients’ needs. Prescribers and patients need this information to evaluate and select treatment options most likely to achieve a desired therapeutic outcome. Health care decision-makers use this information when designing benefits to ensure that safe and effective medications with the best value are provided for all stages of treatment. Such research encourages optimal medication use while also promoting the prudent management of financial resources within the health care system. AMCP believes that the following principles apply to both comparative effectiveness research (CER)1 and patient‐centered outcomes research (PCOR)2 in the context of managed care: the appropriate role of the federal government and other entities (both public and private) in coordinating, funding, and disseminating the results of such research; the characteristics of research design; and the use of research results by patients, providers, and health care decision-makers. 
Comparative Effectiveness Research
Pharmacist
Legislative & Regulatory Position

Cost-Effectiveness Analysis in Healthcare

The Academy of Managed Care Pharmacy (AMCP) supports policies that encourage the incorporation of cost-effectiveness considerations into health care decision-making. Cost-effectiveness analysis (CEA) is a method to assess the value of the clinical outcomes of a treatment relative to the cost. This type of analysis aligns with managed care objectives to optimize patient outcomes, maintain affordability, and encourage sustainability. CEA offers guidance to decisions about coverage and pricing to support managed care strategies—like formulary design, prior authorization, step therapy, and value-based contracting. Policies that promote cost-effectiveness help to ensure patients have access to treatments that deliver meaningful health outcomes at sustainable costs.
Cost-Effectiveness
A group of people in various workforces
Legislative & Regulatory Position

Addressing Systemic Health Disparities in the U.S. Health Care System

AMCP stands against racial and health care injustice. AMCP is committed to 1) mitigating disparities related to optimal medication use, 2) advancing conversations by calling for pertinent submissions to the Journal of Managed Care + Specialty Pharmacy (JMCP) and conducting partnership forum(s), 3) incorporating health equity goals into the strategic plan, and 4) supporting impactful education and policy.
Health Disparities
Underserved Patient
Practice Positions

AMCP Position on Transitions of Care

The Academy of Managed Care Pharmacy (AMCP) recognizes the critical role of pharmacists in ensuring continuity during transitions of care. AMCP strongly supports and advocates for the pharmacist's involvement in collaborative, patient-centered care throughout these transitions.
Person at a computer
Practice Positions

AMCP Position on The Code of Ethics for Pharmacists

The Academy of Managed Care Pharmacy (AMCP) fully endorses the Code of Ethics for Pharmacists established by the American Pharmacists Association (APhA) as the guiding framework for ethical pharmacy practice.
Pharmacists Workshopping
Practice Positions

AMCP Position on Pharmacist Educational Advancement

AMCP encourages schools and colleges of pharmacy to ensure the provision of a balanced, general education, including information regarding emerging technologies and health care systems, to graduate educated and competent health care professionals.
A group of people in various workforces
Practice Positions

AMCP Position on Collaborative Drug Therapy Management

AMCP's perspective on Collaborative Drug Therapy Management (CDTM) in managed care pharmacy. Academy of Managed Care Pharmacy (AMCP) advocates for a collaborative approach to achieving optimal therapeutic outcomes, emphasizing the shared responsibility of the health care team.
Career and Getting a Job - Quality Performance Measures
Practice Positions

AMCP Position on Quality Performance Measures

AMCP has a position on Quality Performance Measures in managed care pharmacy. It recognizes the essential role of pharmacists, PBMs, and health plans in improving the quality of care provided to patients across all lines of business and supports a measure development process that integrates evidence-based medicine and stakeholder feedback in a timely manner.